Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
48
GKOS Quote, Financials, Valuation and Earnings
Last price:
$114.40
Seasonality move
:
-3.17%
Day range:
$103.11 - $114.67
52-week range:
$73.16 - $163.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.82x
P/B ratio:
8.54x
Volume:
1.4M
Avg. volume:
711.4K
1-year change:
-23.56%
Market cap:
$6.6B
Revenue:
$383.5M
EPS (TTM):
-$1.55
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $225M | $294M | $282.9M | $314.7M | $383.5M | |
| Revenue Growth (YoY) | -5.07% | 30.7% | -3.79% | 11.26% | 21.85% | |
| Cost of Revenues | $94.1M | $69M | $71.4M | $78M | $96.4M | |
| Gross Profit | $130.8M | $225M | $211.5M | $236.7M | $287.1M | |
| Gross Profit Margin | 58.15% | 76.52% | 74.76% | 75.22% | 74.86% | |
| R&D Expenses | $85.4M | $101M | $123.3M | $138.8M | $136.4M | |
| Selling, General & Admin | $171.4M | $179.3M | $192.9M | $224.1M | $261.2M | |
| Other Inc / (Exp) | $3M | $15.7M | $15.2M | -$5.6M | -$38.5M | |
| Operating Expenses | $254.4M | $277.8M | $313.8M | $360.4M | $395.2M | |
| Operating Income | -$123.6M | -$52.9M | -$102.3M | -$123.7M | -$108.1M | |
| Net Interest Expenses | $14.1M | $13.4M | $13.7M | $13.6M | $28.1M | |
| EBT. Incl. Unusual Items | -$132.3M | -$49.3M | -$98.4M | -$133.7M | -$145.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$12M | $326K | $766K | $934K | $771K | |
| Net Income to Company | -$120.3M | -$49.6M | -$99.2M | -$134.7M | -$146.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$120.3M | -$49.6M | -$99.2M | -$134.7M | -$146.4M | |
| Basic EPS (Cont. Ops) | -$2.70 | -$1.07 | -$2.09 | -$2.78 | -$2.77 | |
| Diluted EPS (Cont. Ops) | -$2.70 | -$1.07 | -$2.09 | -$2.78 | -$2.77 | |
| Weighted Average Basic Share | $44.5M | $46.4M | $47.4M | $48.4M | $52.8M | |
| Weighted Average Diluted Share | $44.5M | $46.4M | $47.4M | $48.4M | $52.8M | |
| EBITDA | -$88.9M | -$18.5M | -$66.4M | -$85.7M | -$68.2M | |
| EBIT | -$123.6M | -$52.9M | -$102.3M | -$123.7M | -$108.1M | |
| Revenue (Reported) | $225M | $294M | $282.9M | $314.7M | $383.5M | |
| Operating Income (Reported) | -$123.6M | -$52.9M | -$102.3M | -$123.7M | -$108.1M | |
| Operating Income (Adjusted) | -$123.6M | -$52.9M | -$102.3M | -$123.7M | -$108.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $74.7M | $71.3M | $78M | $96.7M | $133.5M | |
| Revenue Growth (YoY) | 15.24% | -4.61% | 9.51% | 23.86% | 38.14% | |
| Cost of Revenues | $15.4M | $16.9M | $18.5M | $22.6M | $28.8M | |
| Gross Profit | $59.3M | $54.4M | $59.5M | $74.1M | $104.7M | |
| Gross Profit Margin | 79.43% | 76.34% | 76.28% | 76.64% | 78.41% | |
| R&D Expenses | $28.8M | $28.9M | $33.3M | $34.7M | $38.1M | |
| Selling, General & Admin | $44.5M | $47.1M | $54.2M | $64M | $83M | |
| Other Inc / (Exp) | $23.5M | -$3M | -$1.7M | $2.4M | -- | |
| Operating Expenses | $73.3M | $76M | $87.5M | $98.7M | $121.1M | |
| Operating Income | -$14M | -$21.6M | -$28M | -$24.7M | -$16.4M | |
| Net Interest Expenses | $3.4M | $3.5M | $3.4M | $1.7M | $1.2M | |
| EBT. Incl. Unusual Items | $6.4M | -$27.3M | -$30.4M | -$21.2M | -$16M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $202K | $247K | $37K | $177K | $234K | |
| Net Income to Company | $6.2M | -$27.6M | -$30.4M | -$21.4M | -$16.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $6.2M | -$27.6M | -$30.4M | -$21.4M | -$16.2M | |
| Basic EPS (Cont. Ops) | $0.13 | -$0.58 | -$0.63 | -$0.39 | -$0.28 | |
| Diluted EPS (Cont. Ops) | $0.13 | -$0.58 | -$0.63 | -$0.39 | -$0.28 | |
| Weighted Average Basic Share | $46.7M | $47.6M | $48.7M | $55M | $57.4M | |
| Weighted Average Diluted Share | $49.3M | $47.6M | $48.7M | $55M | $57.4M | |
| EBITDA | -$5.4M | -$12.6M | -$18.5M | -$15.7M | -$6.2M | |
| EBIT | -$14M | -$21.6M | -$28M | -$24.7M | -$16.4M | |
| Revenue (Reported) | $74.7M | $71.3M | $78M | $96.7M | $133.5M | |
| Operating Income (Reported) | -$14M | -$21.6M | -$28M | -$24.7M | -$16.4M | |
| Operating Income (Adjusted) | -$14M | -$21.6M | -$28M | -$24.7M | -$16.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $294M | $284.9M | $303.6M | $360.3M | $469.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $69.4M | $63M | $68.4M | $78.8M | $108.7M | |
| Gross Profit | $224.7M | $221.9M | $235.2M | $281.6M | $361.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $100.6M | $114.1M | $137.5M | $137M | $143.5M | |
| Selling, General & Admin | $175.5M | $188.6M | $213M | $255.2M | $306.1M | |
| Other Inc / (Exp) | $19.5M | $9M | -$957K | -$32.2M | -- | |
| Operating Expenses | $276M | $302.8M | $349.7M | $391.5M | $449.5M | |
| Operating Income | -$51.4M | -$80.9M | -$114.5M | -$109.9M | -$88.4M | |
| Net Interest Expenses | $15.6M | $13.7M | $13.6M | $29.9M | $5.1M | |
| EBT. Incl. Unusual Items | -$40.9M | -$89.5M | -$128.2M | -$148.6M | -$86.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2.6M | $105K | $1.2M | $946K | $694K | |
| Net Income to Company | -$38.4M | -$89.6M | -$129.3M | -$149.6M | -$87.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$38.4M | -$89.6M | -$129.3M | -$149.6M | -$87.6M | |
| Basic EPS (Cont. Ops) | -$0.84 | -$1.89 | -$2.69 | -$2.96 | -$1.55 | |
| Diluted EPS (Cont. Ops) | -$0.85 | -$1.90 | -$2.69 | -$2.96 | -$1.55 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$16.9M | -$45.4M | -$77M | -$73.4M | -$46.3M | |
| EBIT | -$51.4M | -$80.9M | -$114.5M | -$109.9M | -$88.4M | |
| Revenue (Reported) | $294M | $284.9M | $303.6M | $360.3M | $469.8M | |
| Operating Income (Reported) | -$51.4M | -$80.9M | -$114.5M | -$109.9M | -$88.4M | |
| Operating Income (Adjusted) | -$51.4M | -$80.9M | -$114.5M | -$109.9M | -$88.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $220.8M | $211.6M | $232.3M | $278M | $364.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $49.8M | $51.8M | $56.7M | $65.4M | $80M | |
| Gross Profit | $171M | $159.9M | $175.7M | $212.6M | $284.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $79.3M | $87.5M | $101.7M | $99.9M | $107M | |
| Selling, General & Admin | $131.7M | $141M | $161M | $192.2M | $237M | |
| Other Inc / (Exp) | $16.9M | $10.2M | -$6M | -$32.6M | $2.8M | |
| Operating Expenses | $211M | $228.5M | $262.7M | $292.1M | $344M | |
| Operating Income | -$40M | -$68.6M | -$87.1M | -$79.5M | -$59.7M | |
| Net Interest Expenses | $9.9M | $10.3M | $10.2M | $26.5M | $3.5M | |
| EBT. Incl. Unusual Items | -$27M | -$67.3M | -$97M | -$111.9M | -$53.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $689K | $468K | $873K | $885K | $808K | |
| Net Income to Company | -$27.7M | -$67.7M | -$97.9M | -$112.8M | -$54M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$27.7M | -$67.7M | -$97.9M | -$112.8M | -$54M | |
| Basic EPS (Cont. Ops) | -$0.60 | -$1.43 | -$2.03 | -$2.21 | -$0.95 | |
| Diluted EPS (Cont. Ops) | -$0.61 | -$1.43 | -$2.03 | -$2.21 | -$0.95 | |
| Weighted Average Basic Share | $138.8M | $142M | $144.8M | $155.3M | $171.2M | |
| Weighted Average Diluted Share | $141.3M | $144.5M | $144.8M | $155.3M | $171.2M | |
| EBITDA | -$14.3M | -$41.8M | -$58.7M | -$52.6M | -$30.6M | |
| EBIT | -$40M | -$68.6M | -$87.1M | -$79.5M | -$59.7M | |
| Revenue (Reported) | $220.8M | $211.6M | $232.3M | $278M | $364.3M | |
| Operating Income (Reported) | -$40M | -$68.6M | -$87.1M | -$79.5M | -$59.7M | |
| Operating Income (Adjusted) | -$40M | -$68.6M | -$87.1M | -$79.5M | -$59.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $404.4M | $414.1M | $352.7M | $295.4M | $318.9M | |
| Short Term Investments | $307.8M | $313.3M | $233.2M | $202M | $149.3M | |
| Accounts Receivable, Net | $36.1M | $33.4M | $36.1M | $39.9M | $60.7M | |
| Inventory | $15.8M | $23M | $37.8M | $42M | $57.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $13.2M | $15.6M | $17.3M | $18.2M | $12.5M | |
| Total Current Assets | $469.4M | $486.1M | $443.9M | $395.5M | $449.8M | |
| Property Plant And Equipment | $95.5M | $146.1M | $166.8M | $174.5M | $169.9M | |
| Long-Term Investments | $9.6M | $9.4M | $7.1M | $5.9M | $19.5M | |
| Goodwill | $66.1M | $66.1M | $66.1M | $66.1M | $66.1M | |
| Other Intangibles | $357.7M | $332.8M | $307.9M | $283M | $263.4M | |
| Other Long-Term Assets | $16.8M | $18.5M | $17.7M | $21.3M | $25.4M | |
| Total Assets | $1B | $1.1B | $1.1B | $1B | $1B | |
| Accounts Payable | $4.4M | $7.3M | $14.4M | $13.4M | $13M | |
| Accrued Expenses | $34.5M | $39M | $40.7M | $40M | $40.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $49.7M | $63.4M | $72.4M | $74M | $75.1M | |
| Long-Term Debt | $270.8M | $382.4M | $382.5M | $383.7M | $103.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $338.1M | $541.7M | $544.2M | $545.2M | $269.2M | |
| Common Stock | $45K | $47K | $48K | $49K | $56K | |
| Other Common Equity Adj | $1M | $15K | -$3M | $1.2M | $2.6M | |
| Common Equity | $667.4M | $587.2M | $530M | $461.8M | $766.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $667.4M | $587.2M | $530M | $461.8M | $766.9M | |
| Total Liabilities and Equity | $1B | $1.1B | $1.1B | $1B | $1B | |
| Cash and Short Terms | $404.4M | $414.1M | $352.7M | $295.4M | $318.9M | |
| Total Debt | $270.8M | $382.4M | $382.5M | $383.7M | $104.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $429M | $361.6M | $300.9M | $262.5M | $273.7M | |
| Short Term Investments | $315.8M | $257.6M | $191.9M | $162.3M | -- | |
| Accounts Receivable, Net | $35.2M | $34.8M | $39.3M | $56.4M | $98.7M | |
| Inventory | $19.7M | $34.2M | $39.8M | $59.9M | $63.9M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $17.9M | $18.3M | $19.6M | $18.5M | -- | |
| Total Current Assets | $501.8M | $448.8M | $399.5M | $397.3M | $454.8M | |
| Property Plant And Equipment | $139.2M | $160.6M | $175.1M | $168.3M | $182.5M | |
| Long-Term Investments | $9.4M | $9.1M | $5.9M | $19.5M | $22.6M | |
| Goodwill | $66.1M | $66.1M | $66.1M | $66.1M | -- | |
| Other Intangibles | $339M | $314.1M | $289.2M | $269.4M | -- | |
| Other Long-Term Assets | $18M | $18.8M | $18.7M | $25.4M | -- | |
| Total Assets | $1.1B | $1B | $948.6M | $926.5M | $999.4M | |
| Accounts Payable | $8.5M | $11.5M | $10.4M | $11.1M | $19.9M | |
| Accrued Expenses | $37.1M | $37.2M | $38M | $37.3M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $63.5M | $60.6M | $67.1M | $71.7M | $87.5M | |
| Long-Term Debt | $382.4M | $382.5M | $383.8M | $157.1M | $104.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $463.1M | $459.9M | $471M | $258M | $229.8M | |
| Common Stock | $47K | $48K | $49K | $55K | $57K | |
| Other Common Equity Adj | $987K | -$3.8M | $764K | $2.6M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $601M | $548.6M | $477.7M | $668.5M | $769.5M | |
| Total Liabilities and Equity | $1.1B | $1B | $948.6M | $926.5M | $999.4M | |
| Cash and Short Terms | $429M | $361.6M | $300.9M | $262.5M | $273.7M | |
| Total Debt | $382.4M | $382.5M | $383.8M | $157.1M | $104.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$120.3M | -$49.6M | -$99.2M | -$134.7M | -$146.4M | |
| Depreciation & Amoritzation | $34.6M | $34.4M | $35.9M | $38M | $39.9M | |
| Stock-Based Compensation | $46.5M | $30.1M | $38.6M | $43.5M | $50.2M | |
| Change in Accounts Receivable | $2.2M | $1.7M | -$3.1M | -$3.8M | -$22M | |
| Change in Inventories | $2M | -$7.7M | -$15.5M | -$4.8M | -$18.8M | |
| Cash From Operations | -$23M | $24.7M | -$33.1M | -$57.8M | -$61.3M | |
| Capital Expenditures | $6.9M | $47.8M | $30.3M | $20.2M | $6.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$205.1M | -$58.2M | $44.8M | $14.1M | $47.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $287.5M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$659K | -$527K | -$711K | -$1.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$49.2M | $9M | -$2.4M | -$3.3M | $46.4M | |
| Cash From Financing | $262.5M | $39.3M | $6.3M | $15M | $91.5M | |
| Beginning Cash (CF) | $96.6M | $100.7M | $119.5M | $93.5M | $169.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $34.4M | $4M | $16.5M | -$27.3M | $75M | |
| Ending Cash (CF) | $130.9M | $102.9M | $134.5M | $67.5M | $241.6M | |
| Levered Free Cash Flow | -$29.9M | -$23.1M | -$63.3M | -$78M | -$67.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.2M | -$27.6M | -$30.4M | -$21.4M | -$16.2M | |
| Depreciation & Amoritzation | $8.6M | $9M | $9.5M | $6.9M | $10.2M | |
| Stock-Based Compensation | $6.2M | $9.4M | $10.5M | $14.4M | $14.9M | |
| Change in Accounts Receivable | $2.2M | $175K | -$435K | -$4.5M | -$18.8M | |
| Change in Inventories | -$2.4M | -$6.7M | -$620K | -$3.1M | $659K | |
| Cash From Operations | $17.8M | -$26.5M | -$8.2M | -$9.6M | -$10.1M | |
| Capital Expenditures | $9.9M | $6M | $3.4M | $1.5M | $1.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$26.1M | $24.4M | $14.9M | $30.6M | -$4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$102K | -$144K | -$190K | -$242K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$858K | -$445K | -$768K | -$328K | -- | |
| Cash From Financing | $3.9M | $4.2M | $7.5M | $9.7M | $5.3M | |
| Beginning Cash (CF) | $113.1M | $104M | $108.9M | $100.1M | $98.2M | |
| Foreign Exchange Rate Adjustment | -$759K | -$667K | -$79K | $1.4M | $6.3M | |
| Additions / Reductions | -$5.2M | $1.4M | $14.1M | $32.1M | -$2.6M | |
| Ending Cash (CF) | $107.2M | $104.8M | $123M | $133.6M | $101.9M | |
| Levered Free Cash Flow | $7.9M | -$32.6M | -$11.5M | -$11M | -$11.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$38.4M | -$89.6M | -$129.3M | -$149.6M | -$87.6M | |
| Depreciation & Amoritzation | $34.5M | $35.5M | $37.5M | $36.5M | $42.1M | |
| Stock-Based Compensation | $31.7M | $34.1M | $42.2M | $49.9M | $59.2M | |
| Change in Accounts Receivable | -$2.9M | -$1.9M | -$3.6M | -$16.8M | -$48.3M | |
| Change in Inventories | -$24.9M | -$15.3M | -$6.5M | -$20.1M | -$4.4M | |
| Cash From Operations | $40M | -$33.6M | -$51.2M | -$72.5M | -$21.1M | |
| Capital Expenditures | $40.6M | $31.4M | $24.3M | $8.8M | $6.5M | |
| Cash Acquisitions | -- | -- | -- | -- | $12.4M | |
| Cash From Investing | -$52.8M | $19.3M | $43.7M | $23.1M | -$49.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$555K | -$484K | -$664K | -$859K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $7.7M | -$2.4M | -$4.7M | -$3.5M | -- | |
| Cash From Financing | $46.3M | $7.3M | $8.3M | $38.7M | $69.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $32.2M | -$9.5M | $1.7M | -$9.9M | -$2.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$640K | -$65M | -$75.5M | -$81.3M | -$27.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$27.7M | -$67.7M | -$97.9M | -$112.8M | -$54M | |
| Depreciation & Amoritzation | $25.7M | $26.8M | $28.4M | $26.9M | $29.1M | |
| Stock-Based Compensation | $22.9M | $26.9M | $30.5M | $36.9M | $45.9M | |
| Change in Accounts Receivable | $494K | -$3.1M | -$3.5M | -$16.5M | -$42.8M | |
| Change in Inventories | -$4.3M | -$11.9M | -$2.9M | -$18.2M | -$3.7M | |
| Cash From Operations | $29.4M | -$28.9M | -$47.1M | -$61.8M | -$21.6M | |
| Capital Expenditures | $38.5M | $22M | $16M | $4.6M | $4.8M | |
| Cash Acquisitions | -- | -- | -- | -- | $12.4M | |
| Cash From Investing | -$49.4M | $28.1M | $27M | $36M | -$61.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$555K | -$380K | -$517K | -$665K | -$526K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $9M | -$2.4M | -$4.6M | -$4.8M | -$7.3M | |
| Cash From Financing | $37.6M | $5.7M | $7.7M | $31.4M | $9.5M | |
| Beginning Cash (CF) | $328.1M | $312.8M | $280.1M | $210.7M | $313.3M | |
| Foreign Exchange Rate Adjustment | -$1.3M | -$1.9M | $520K | -$93K | $1.6M | |
| Additions / Reductions | $16.4M | $3M | -$11.8M | $5.6M | -$72.3M | |
| Ending Cash (CF) | $343.2M | $313.8M | $268.8M | $216.2M | $242.6M | |
| Levered Free Cash Flow | -$9.1M | -$51M | -$63.1M | -$66.4M | -$26.4M | |
Get GKOS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GKOS
Sector
P/E ratio
--
23.92x
PEG ratio
-31.08x
-0.01x
P/B ratio
8.54x
1.81x
Price / LTM sales
13.82x
1.60x
Growth Metrics
GKOS
Sector
Revenue growth
38.14%
4.35%
Earnings growth
27.3%
9.8%
Revenue (5-year growth)
10.11%
6.41%
Earnings forecast
-$0.22
-$0.18
Profitability
GKOS
Sector
Profitability FY 2024
$287.1M
$3.3M
Return on invested capital
-10.16%
-32.69%
Return on assets
-8.91%
-29.29%
Return on equity
-11.73%
-38.5%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
17
Estimated Next Earnings Date
Jan
28
Balance Sheet
GKOS
Sector
Total cash
$273.7M
$25.6M
Short term investments
$149.3M
$25.1M
Total assets
$1B
$75.5M
Long term debt
$104.3M
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 64x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
80
BNR alert for Jan 16
Burning Rock Biotech Ltd. [BNR] is down 3.96% over the past day.
Buy
90
PEN alert for Jan 16
Penumbra, Inc. [PEN] is up 0.15% over the past day.
Buy
100
TLN alert for Jan 16
Talen Energy Corp. [TLN] is down 8.49% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
